Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management — TRIUMPH

Ulcerative Colitis Acute Clinical Trial

Official title:
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (the TRIUMPH Study)

Status Active, not recruiting

Clinical Trial Summary

The TRIUMPH study was designed to build on the existing literature by studying the efficacy of tofacitinib in hospitalized patients with acute severe ulcerative colitis. This trial will provide evidence for a possible new indication for the use of tofacitinib.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04925973
Study type	Interventional
Source	McMaster University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	June 1, 2021
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05867329` - A Trial for Acute Severe Ulcerative Colitis	Phase 4
Recruiting	`NCT05466890` - Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)	Phase 2
Completed	`NCT03578692` - Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC)
Completed	`NCT05219656` - Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.
Recruiting	`NCT05998213` - Transfer of Feces in Ulcerative Colitis 2	Phase 2